Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-10

Clinical Trial Update: Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

View source ↗

Summary

Retrospective observational study examining reasons for withdrawal from adjuvant tamoxifen in breast cancer patients. The study is completed and sponsored by As…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED